Athyrium Capital Management as of March 31, 2023
Portfolio Holdings for Athyrium Capital Management
Athyrium Capital Management holds 8 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Puma Biotechnology (PBYI) | 0.0 | $0 | 0 | 0.00 | |
| Rvl Pharmaceuticals SHS (RVLPQ) | 0.0 | $0 | 0 | 0.00 | |
| Paratek Pharmaceuticals Note 4.750% 5/0 (Principal) | 0.0 | $0 | 0 | 0.00 | |
| Omeros Corp Note 6.250%11/1 (Principal) | 0.0 | $0 | 0 | 0.00 | |
| Omeros Corp Note 5.250% 2/1 (Principal) | 0.0 | $0 | 0 | 0.00 | |
| Amryt Pharma Sponsored ADS | 0.0 | $0 | 0 | 0.00 | |
| Biora Note 7.250% 12/0 (Principal) | 0.0 | $0 | 0 | 0.00 | |
| Biora Therapeutics Ord (BIOR) | 0.0 | $0 | 0 | 0.00 |
